The Enduring Investment Thesis: Why Biosafety is a Long-Term Play The global focus on pandemic preparedness and advanced healthcare infrastructure has fundamentally shifted, creating a robust and enduring investment landscape within the biosafety and infection control sector. This is not merely a reactive market born from recent health crises; it is a proactive and expanding field driven by stringent government regulations, technological advancements in biotechnology, and a heightened collective awareness of microbial threats. Investing in this sector means betting on the continuous need for safety in laboratories, hospitals, and manufacturing facilities worldwide. The demand for personal protective equipment (PPE), sterilization equipment, advanced disinfectants, and high-containment laboratory supplies is now embedded…